The shame, blame and stigma surrounding this deadly disease affects everything from patient follow-through to research funding
Nov. 21, 2017
| By Diane Mapes / Fred Hutch News Service
Most people know that lung cancer is an aggressive killer, triggered by everything from smoking to genetic mutations to environmental toxins. But more and more patients, doctors and researchers are pointing to another harmful influence contributing to the suffering, delayed diagnosis and possibly even early deaths of those hit with the disease: stigma.
‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors
April 4, 2017
| By Rachel Tompa / Fred Hutch News Service
A major roadblock to adopting T-cell therapy to solid tumors is what’s known as the tumor microenvironment, the local milieu of non-cancerous cells and molecules in and around the tumor. Fred Hutch researcher Dr. Kristin Anderson and her colleagues in Dr. Phil Greenberg's lab are working to overcome those barriers.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.